Moleculin Biotech
(NASDAQ) MBRX
Moleculin Biotech Financials at a Glance
Market Cap
$15.37M
Revenue (TTM)
$0.00
Net Income (TTM)
-$30.33M
EPS (TTM)
-$28.04
P/E Ratio
-0.10
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$2.88
Volume
6,045
Open
$2.91
Price
$2.88
Volume
6,045
Open
$2.91
Previous Close
$2.88
Daily Range
$2.81 - $2.93
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.82 (Low)
Price
$2.88
Volume
6,045
Open
$2.91
Previous Close
$2.88
Daily Range
$2.81 - $2.93
52-Week Range
$1.79 - $24.00
Estimated Earnings Date
Aug 11, 2026
MBRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Moleculin Biotech
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Walter V. Klemp, CPA
Website
www.moleculin.comHeadquarters
Houston, TX 77007, US
MBRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-398%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-10.00%
Dividend Yield
0.00%
Payout Ratio
-5.82%
Stock Overview
Market Cap
$15.37M
Shares Outstanding
5.34M
Volume
6.04K
Avg. Volume
184.98K
Financials (TTM)
Gross Profit
-$90.00K
Operating Income
-$25.10M
EBITDA
-$33.47M
Operating Cash Flow
-$22.74M
Capital Expenditure
$0.00
Free Cash Flow
-$22.74M
Cash & ST Invst.
$8.88M
Total Debt
$359.00K
Moleculin Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$8.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$15.37M
N/A
Market Cap/Employee
$904.04K
N/A
Employees
17
N/A
Net Income
-$12.85M
-99.6%
EBITDA
-$12.84M
-100.4%
Quarterly Fundamentals
Total Cash
$10.32M
+33.7%
Total Debt
$326.00K
-27.6%
Accounts Receivable
$9.00K
+50.0%
Inventory
$0.00
N/A
Long Term Debt
$185.00K
-43.3%
Short Term Debt
$141.00K
+13.7%
Return on Assets
-1.30%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
-$6.11M
-33.9%
Operating Cash Flow
-$6.11M
-33.9%